Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 32Carcinoma, Intraductal, Noninfiltrating 7Breast Carcinoma In Situ 4Prostatic Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Infertility 2Breast Neoplasms, Male 2Breast Diseases 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Precancerous Conditions 1Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Pancreatic Cyst 1Neoplasms by Site 1Hypogonadism 1Hot Flashes 1Hereditary Sensory and Autonomic Neuropathies 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Carcinoma, Ductal 1Anovulation 1Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

exemestane 2Tamoxifen 2Letrozole 2Immunotherapy 2Anastrozole 2ribociclib 1elacestrant 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1abemaciclib 1Taxes 1Standard of Care 1Radiosurgery 1Psychiatric Rehabilitation 1Practice Guidelines as Topic 1Neoadjuvant Therapy 1Methods 1Mental Status and Dementia Tests 1Leuprolide 1Interviews as Topic 1Goserelin 1Genetic Testing 1Genetic Counseling 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Breast Neoplasms, Male × Tamoxifen × 90 days × Clear all
NCT06492616 2026-05-27

ELEGANT

Stemline Therapeutics, Inc.

Phase 3 Recruiting
4,220 enrolled
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT05501704 2026-04-30

ETHAN - ET for Male BC

Dana-Farber Cancer Institute

Phase 2 Recruiting
60 enrolled
Breast

Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡